Cardiac Disease in Adolescents With Delayed Diagnosis of Vertically Acquired HIV Infection
Open Access
- 24 October 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 56 (4) , 576-582
Abstract
Background. At least one-third of human immunodeficiency virus (HIV)–infected infants survive to adolescence even without antiretroviral therapy (ART), but are at high risk of complications including cardiac disease. We investigated the characteristics of cardiac disease among adolescents with HIV infection diagnosed in late childhood who were receiving ambulatory HIV care in Harare, Zimbabwe. Methods. Consecutive adolescents with vertically acquired HIV attending 2 HIV outpatient treatment clinics were studied. Assessment included clinical history and examination, and 2-dimensional, M-mode, pulsed- and continuous-wave Doppler echocardiography. Results. Of 110 participants (47% male; median age, 15 years; interquartile range, 12–17 years), 78 (71%) were taking ART. Exertional dyspnea, chest pain, palpitations, and ankle swelling were reported by 47 (43%), 43 (39%), 10 (9%), and 7 (6%), respectively. The New York Heart Association score was ≥2 in 41 participants (37%). Echocardiography showed that 74 participants (67%) had left ventricular (LV; septal and/or free wall) hypertrophy and 27 (24%) had evidence of impaired LV relaxation or restrictive LV physiology. The estimated pulmonary artery systolic pressure (ePASP) was >30 mm Hg in 4 participants (3.6%); of these 2 also had right ventricular (RV) dilatation. Another 32 participants (29%), without elevated ePASP, had isolated RV dilatation. Conclusions. A significant burden of cardiac disease was seen among adolescents with vertically acquired HIV infection. More than half were asymptomatic yet had significant echocardiographic abnormalities. These findings highlight the need to screen this population in order to better define the geography, natural history, etiopathogenic mechanisms, and management (including the timing and choice of optimal therapeutic ART and cardiac drug interventions) to prevent development and/or progression of HIV-associated cardiac disease.Keywords
This publication has 37 references indexed in Scilit:
- Chronic Lung Disease in Adolescents With Delayed Diagnosis of Vertically Acquired HIV InfectionClinical Infectious Diseases, 2012
- Truncations of Titin Causing Dilated CardiomyopathyNew England Journal of Medicine, 2012
- Update on MyocarditisJACC, 2012
- Causes of Acute Hospitalization in Adolescence: Burden and Spectrum of HIV-Related Morbidity in a Country with an Early-Onset and Severe HIV Epidemic: A Prospective SurveyPLOS Medicine, 2010
- AIDS among older children and adolescents in Southern Africa: projecting the time course and magnitude of the epidemicAIDS, 2009
- A Novel Method of Expressing Left Ventricular Mass Relative to Body Size in ChildrenCirculation, 2008
- HIV Infection Presenting in Older Children and Adolescents: A Case Series from Harare, ZimbabweClinical Infectious Diseases, 2007
- Projecting the demographic impact of AIDS and the number of people in need of treatment: updates to the Spectrum projection packageSexually Transmitted Infections, 2006
- Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: The Prospective P2C2 HIV Multicenter StudyAmerican Heart Journal, 2005
- Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography.Circulation, 1980